Comparative evaluation of first- and second-generation digene hybrid capture assays for detection of human papillomaviruses associated with high or intermediate risk for cervical cancer.

Comparative evaluation of first- and second-generation digene hybrid capture assays for detection of human papillomaviruses associated with high or intermediate risk for cervical cancer.

Item
http://www.wikidata.org/entity/Q33959397
Cross sectional study of conventional cervical smear, monolayer cytology, and human papillomavirus DNA testing for cervical cancer screeningComparison between the Hybrid Capture II test and a PCR-based human papillomavirus detection method for diagnosis and posttreatment follow-up of cervical intraepithelial neoplasia.Assessment of MagNA pure LC extraction system for detection of human papillomavirus (HPV) DNA in PreservCyt samples by the Roche AMPLICOR and LINEAR ARRAY HPV tests.Comparison of clinical and analytical performance of the Abbott Realtime High Risk HPV test to the performance of hybrid capture 2 in population-based cervical cancer screening.A pilot analytic study of a research-level, lower-cost human papillomavirus 16, 18, and 45 test.Impact of age on the false negative rate of human papillomavirus DNA test in patients with atypical squamous cells of undetermined significance.Comparison of the Digene Hybrid Capture 2 assay and Roche AMPLICOR and LINEAR ARRAY human papillomavirus (HPV) tests in detecting high-risk HPV genotypes in specimens from women with previous abnormal Pap smear results.Comparison of the Abbott RealTime High-Risk Human Papillomavirus (HPV), Roche Cobas HPV, and Hybrid Capture 2 assays to direct sequencing and genotyping of HPV DNA.Comparison of hybrid capture II, linear array, and a bead-based multiplex genotyping assay for detection of human papillomavirus in women with negative pap test results and atypical squamous cells of undetermined significance.Clinical validation of a type-specific real-time quantitative human papillomavirus PCR against the performance of hybrid capture 2 for the purpose of cervical cancer screening.Comparison of Analytical and Clinical Performance of HPV 9G DNA Chip, PANArray HPV Genotyping Chip, and Hybrid-Capture II Assay in Cervicovaginal Swabs.Quantitative screening of single copies of human papilloma viral DNA without amplificationHuman papillomavirus genotype specificity of hybrid capture 2 low-risk probe cocktail.Evaluation of the Clinical Performance of the HPV-Risk Assay Using the VALGENT-3 Panel.
P2860

Comparative evaluation of first- and second-generation digene hybrid capture assays for detection of human papillomaviruses associated with high or intermediate risk for cervical cancer.

Item
http://www.wikidata.org/entity/Q33959397
description
1999 nî lūn-bûn
@nan
1999 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի մարտին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Comparative evaluation of firs ...... iate risk for cervical cancer.
@ast
Comparative evaluation of firs ...... iate risk for cervical cancer.
@en
type
label
Comparative evaluation of firs ...... iate risk for cervical cancer.
@ast
Comparative evaluation of firs ...... iate risk for cervical cancer.
@en
prefLabel
Comparative evaluation of firs ...... iate risk for cervical cancer.
@ast
Comparative evaluation of firs ...... iate risk for cervical cancer.
@en
P1433
P1476
P2093
P2860
P304
P31
P407
P433
P478
P50
P577
P698
P932
P1433
P1476
Comparative evaluation of firs ...... diate risk for cervical cancer
@en
P2093
P2860
P304
P31
P407
P433
P478
P50
P577
P698
P932